Andere talen MediPal Holdings Corporation

Aandelen

7459

JP3268950007

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.413 ^JPY	-0,82%		+1,17%	+5,58%

2023	MEDIPAL Holdings Corporation en JCR Pharmaceuticals Co. Sluiten twee overeenkomsten voor de behandeling van Mucopolysaccharidosis Type IIIB	CI
2023	MediPal Holdings Corporation rapporteert resultaten voor het gehele jaar eindigend op 31 maart 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023.	18/12
MediPal Holdings Corporation's Equity Buyback announced on May 12, 2023 has closed with 4,171,900 shares, representing 1.97% for ¥9,999.86 million.	18/12
MediPal : Notice of Basic Agreement concerning Integration between Consolidated Subsidiaries	02/11
MediPal : Notice Regarding Progress of Acquisition of Treasury Stock	02/11
Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023.	03-10-23
MEDIPAL Holdings Corporation and JCR Pharmaceuticals Co., Ltd. Conclude Two Agreements on Mucopolysaccharidosis Type IIIB Treatment	28-09-23
Tranche Update on MediPal Holdings Corporation's Equity Buyback Plan announced on May 12, 2023.	03-07-23
MediPal Holdings Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	12-05-23
MediPal Holdings Corporation announces an Equity Buyback for 5,800,000 shares, representing 2.71% for ¥10,000 million.	12-05-23
MediPal Holdings Corporation authorizes a Buyback Plan.	12-05-23
Sumitomo Pharma Announces Completion of Share Transfer of Consolidated Subsidiary, Sumitomo Pharma Food and Chemical	03-04-23
Japan Index Rises on Oil Price Surge; Polaris Appoints President, CFO	03-04-23
Sumitomo Pharma Closes Sale of Food, Chemical Subsidiary to Medipal	03-04-23
MediPal Holdings Corporation acquired Toshichi Co.,Ltd.	03-04-23
MediPal Holdings Corporation completed the acquisition of Sumitomo Pharma FOOD & CHEMICAL Co., LTD. from Sumitomo Pharma Co., Ltd..	31-03-23
Layered Co., Ltd. announced that it has received funding from MediPal Holdings Corporation, FFG Venture Business Partners Co., Ltd.	16-01-23
Nichi-Iko Pharmaceutical Secures 98.5 Billion Yen of Debt Relief, Plans 20 Billion Yen Share Allotment; Shares Plunge 20%	30-12-22
Sumitomo Pharma Announces Transfer of Shares of a Consolidated Subsidiary, Sumitomo Pharma Food & Chemical	01-12-22
MediPal Holdings Corporation entered into a Share Purchase agreement to acquire Sumitomo Pharma FOOD & CHEMICAL Co., LTD. from Sumitomo Pharma Co., Ltd..	30-11-22
MEDIPAL and JCR Agree on the Granting of Exclusive Negotiation Rights for Global Commercialization Targeting Four Ultra-Rare Diseases and Concl	31-10-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen MediPal Holdings Corporation

Aandelen

7459

JP3268950007

Andere talen

Filters